A Randomized, Open-label, Single dose, 2-Treatment, 2-Period, 2-Way Crossover Study to Assess Pharmacokinetics of a Clopidogrel and Aspirin combination capsule Compared with a Clopidogrel Tablet and Aspirin capsule under Fasted Conditions in Healthy Male Subjects

Trial Profile

A Randomized, Open-label, Single dose, 2-Treatment, 2-Period, 2-Way Crossover Study to Assess Pharmacokinetics of a Clopidogrel and Aspirin combination capsule Compared with a Clopidogrel Tablet and Aspirin capsule under Fasted Conditions in Healthy Male Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs Aspirin/clopidogrel (Primary) ; Aspirin; Clopidogrel
  • Indications Coronary disorders; Embolism and thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 12 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top